|
1
|
Bernstein L, Linet M and Smith MA: Cancer
Incidence and Survival Among Children and Adolescents: United
States SEER Program, 1975-1995. National Cancer Institute;
Bethesda, MD: pp. p791999
|
|
2
|
Grovas A, Fremgen A, Rauck A, Ruymann FB,
Hutchinson CL, Winchester DP and Menck HR: The National Cancer Data
Base report on patterns of childhood cancers in the United States.
Cancer. 80:2321–2332. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Koshinaga T, Takimoto T, Oue T, Okita H,
Tanaka Y, Nozaki M, Tsuchiya K, Inoue E, Haruta M, Kaneko Y, et al:
Outcome of renal tumors registered in Japan Wilms Tumor Study-2
(JWiTS-2): A report from the Japan Children's Cancer Group (JCCG).
Pediatr Blood Cancer. 65:e270562018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Metzger ML and Dome JS: Current therapy
for Wilms' tumor. Oncologist. 10:815–826. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smith GR, Thomas PR, Ritchey M and Norkool
P: Long-term renal function in patients with irradiated bilateral
Wilms tumor. National Wilms' Tumor Study Group. Am J Clin Oncol.
21:58–63. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Green DM, Grigoriev YA, Nan B, Takashima
JR, Norkool PA, D'Angio GJ and Breslow NE: Congestive heart failure
after treatment for Wilms' tumor: A report from the National Wilms'
Tumor Study group. J Clin Oncol. 19:1926–1934. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Green DM, Norkool P, Breslow NE,
Finklestein JZ and D'Angio GJ: Severe hepatic toxicity after
treatment with vincristine and dactinomycin using single-dose or
divided-dose schedules: A report from the National Wilms' Tumor
Study. J Clin Oncol. 8:1525–1530. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Green DM, Peabody EM, Nan B, Peterson S,
Kalapurakal JA and Breslow NE: Pregnancy outcome after treatment
for Wilms tumor: A report from the National Wilms Tumor Study
Group. J Clin Oncol. 20:2506–2513. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
van Dijk IW, Oldenburger F, Cardous-Ubbink
MC, Geenen MM, Heinen RC, de Kraker J, van Leeuwen FE, van der Pal
HJ, Caron HN, Koning CC, et al: Evaluation of late adverse events
in long-term Wilms' tumor survivors. Int J Radiat Oncol Biol Phys.
78:370–378. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Howlader N, Noone AM, Krapcho M, Miller D,
Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, et al:
SEER Cancer Statistics Review, 1975–2014. NIH publication National
Cancer Institute. (Bethesda, MD). p9962017.
|
|
11
|
International Human Genome Sequencing
Consortium, . Finishing the euchromatic sequence of the human
genome. Nature. 431:931–945. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang K, Lu C, Huang X, Cui J, Li J, Gao
Y, Liang W, Liu Y, Sun Y, Liu H, et al: Long noncoding RNA AOC4P
regulates tumor cell proliferation and invasion by
epithelial-mesenchymal transition in gastric cancer. Therap Adv
Gastroenterol. 12:17562848198276972019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tran DDH, Kessler C, Niehus SE, Mahnkopf
M, Koch A and Tamura T: Myc target gene, long intergenic noncoding
RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and
cell survival by titrating tumor suppressor microRNAs. Oncogene.
37:75–85. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang M, Guo C, Wang L, Luo G, Huang C, Li
Y, Liu D, Zeng F, Jiang G and Xiao X: Long noncoding RNA GAS5
promotes bladder cancer cells apoptosis through inhibiting EZH2
transcription. Cell Death Dis. 9:2382018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu H, Zheng JF, Hou CZ, Li Y and Liu PS:
Up-regulation of long intergenic noncoding RNA 01296 in ovarian
cancer impacts invasion, apoptosis and cell cycle distribution via
regulating EMT. Cell Signal. 62:1093412019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dong X, Jin Z, Chen Y, Xu H, Ma C, Hong X,
Li Y and Zhao G: Knockdown of long non-coding RNA ANRIL inhibits
proliferation, migration, and invasion but promotes apoptosis of
human glioma cells by upregulation of miR-34a. J Cell Biochem.
119:2708–2718. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qu Z and Li S: Long noncoding RNA
LINC01278 favors the progression of osteosarcoma via modulating
miR-133a-3p/PTHR1 signaling. J Cell Physiol. Jan 29–2020.(Epub
ahead of print). doi: 10.1002/jcp.29582. View Article : Google Scholar
|
|
22
|
Xu W, Yu S, Xiong J, Long J, Zheng Y and
Sang X: CeRNA regulatory network-based analysis to study the roles
of noncoding RNAs in the pathogenesis of intrahepatic
cholangiocellular carcinoma. Aging (Albany NY). 12:1047–1086. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Su L, Wu A, Zhang W and Kong X: Silencing
long non-coding RNA SNHG6 restrains proliferation, migration and
invasion of Wilms' tumour cell lines by regulating miR-15a. Artif
Cells Nanomed Biotechnol. 47:2670–2677. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu KR, Sun QF and Zhang YQ: Long
non-coding RNA LINP1 induces tumorigenesis of Wilms' tumor by
affecting Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol
Sci. 23:5691–5698. 2019.PubMed/NCBI
|
|
25
|
Liu Z, He F, OuYang S, Li Y, Ma F, Chang
H, Cao D and Wu J: miR-140-5p could suppress tumor proliferation
and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT
signaling pathways in Wilms' tumor. BMC Cancer. 19:4052019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu S, Fu W, Zhang L, Fu K, Hu J, Jia W
and Liu G: LINC00473 antagonizes the tumour suppressor miR-195 to
mediate the pathogenesis of Wilms tumour via IKKalpha. Cell Prolif.
Feb 51–2018.(Epub ahead of print). doi: 10.1111/cpr.12416.
View Article : Google Scholar
|
|
27
|
Ludwig N, Werner TV, Backes C, Trampert P,
Gessler M, Keller A, Lenhof HP, Graf N and Meese E: Combining miRNA
and mRNA expression profiles in Wilms tumor subtypes. Int J Mol
Sci. 17:4752016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ritchey ML, Shamberger RC, Haase G,
Horwitz J, Bergemann T and Breslow NE: Surgical complications after
primary nephrectomy for Wilms' tumor: Report from the National
Wilms' Tumor Study Group. J Am Coll Surg. 192:63–68, quiz 146.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Termuhlen AM, Tersak JM, Liu Q, Yasui Y,
Stovall M, Weathers R, Deutsch M, Sklar CA, Oeffinger KC, Armstrong
G, et al: Twenty-five year follow-up of childhood Wilms tumor: A
report from the Childhood Cancer Survivor Study. Pediatr Blood
Cancer. 57:1210–1216. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cotton CA, Peterson S, Norkool PA,
Takashima J, Grigoriev Y, Green DM and Breslow NE: Early and late
mortality after diagnosis of wilms tumor. J Clin Oncol.
27:1304–1309. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Marchese FP, Raimondi I and Huarte M: The
multidimensional mechanisms of long noncoding RNA function. Genome
Biol. 18:2062017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hon CC, Ramilowski JA, Harshbarger J,
Bertin N, Rackham OJ, Gough J, Denisenko E, Schmeier S, Poulsen TM,
Severin J, et al: An atlas of human long non-coding RNAs with
accurate 5 ends. Nature. 543:199–204. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang L, Wang C, Wu T and Sun F: Long
non-coding RNA TP73-AS1 promotes TFAP2B-mediated proliferation,
metastasis and invasion in retinoblastoma via decoying of
miRNA-874-3p. J Cell Commun Signal. Feb 18–2020.(Epub ahead of
print). doi: 10.1007/s12079-020-00550-x. View Article : Google Scholar
|
|
38
|
Wang J, Cao Y, Lu X, Wang X, Kong X, Bo C,
Li S, Bai M, Jiao Y, Gao H, et al: Identification of the regulatory
role of lncRNA SNHG16 in myasthenia gravis by constructing a
competing endogenous RNA Network. Mol Ther Nucleic Acids.
19:1123–1133. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu J, Zhang J, Shan F, Wen J and Wang Y:
SSTR5 AS1 functions as a ceRNA to regulate CA2 by sponging miR 15b
5p for the development and prognosis of HBV related hepatocellular
carcinoma. Mol Med Rep. 20:5021–5031. 2019.PubMed/NCBI
|
|
40
|
Chi R, Chen X, Liu M, Zhang H, Li F, Fan
X, Wang W and Lu H: Role of SNHG7-miR-653-5p-STAT2 feedback loop in
regulating neuroblastoma progression. J Cell Physiol.
234:13403–13412. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fei D, Zhang X, Liu J, Tan L, Xing J, Zhao
D and Zhang Y: Long noncoding RNA FER1L4 suppresses tumorigenesis
by regulating the expression of PTEN targeting miR-18a-5p in
osteosarcoma. Cell Physiol Biochem. 51:1364–1375. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Arai E, Gotoh M, Tian Y, Sakamoto H, Ono
M, Matsuda A, Takahashi Y, Miyata S, Totsuka H, Chiku S, et al:
Alterations of the spindle checkpoint pathway in
clinicopathologically aggressive CpG island methylator phenotype
clear cell renal cell carcinomas. Int J Cancer. 137:2589–2606.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hohenstein P, Pritchard-Jones K and
Charlton J: The yin and yang of kidney development and Wilms'
tumors. Genes Dev. 29:467–482. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kurtzeborn K, Kwon HN and Kuure S:
MAPK/ERK signaling in regulation of renal differentiation. Int J
Mol Sci. 20:E17792019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xie M, Zhang Z and Cui Y: Long Noncoding
RNA SNHG1 contributes to the promotion of prostate cancer cells
through regulating miR-377-3p/AKT2 axis. Cancer Biother Radiopharm.
35:109–119. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Meng X, Deng Y, Lv Z, Liu C, Guo Z, Li Y,
Liu H, Xie B, Jin Z, Lin F, et al: LncRNA SNHG5 promotes
proliferation of glioma by regulating miR-205-5p/ZEB2 axis.
OncoTargets Ther. 12:11487–11496. 2019. View Article : Google Scholar
|
|
47
|
Krystal GW, Armstrong BC and Battey JF:
N-myc mRNA forms an RNA-RNA duplex with endogenous antisense
transcripts. Mol Cell Biol. 10:4180–4191. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Armstrong BC and Krystal GW: Isolation and
characterization of complementary DNA for N-cym, a gene encoded by
the DNA strand opposite to N-myc. Cell Growth Differ. 3:385–390.
1992.PubMed/NCBI
|
|
49
|
O'Brien EM, Selfe JL, Martins AS, Walters
ZS and Shipley JM: The long non-coding RNA MYCNOS-01 regulates MYCN
protein levels and affects growth of MYCN-amplified
rhabdomyosarcoma and neuroblastoma cells. BMC Cancer. 18:2172018.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhao X, Li D, Pu J, Mei H, Yang D, Xiang
X, Qu H, Huang K, Zheng L and Tong Q: CTCF cooperates with
noncoding RNA MYCNOS to promote neuroblastoma progression through
facilitating MYCN expression. Oncogene. 35:3565–3576. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Xie ZZ, Xiao ZC, Song YX, Li W and Tan GL:
Long non-coding RNA Dleu2 affects proliferation, migration and
invasion ability of laryngeal carcinoma cells through triggering
miR-16-1 pathway. Eur Rev Med Pharmacol Sci. 22:1963–1970.
2018.PubMed/NCBI
|
|
52
|
Lerner M, Harada M, Lovén J, Castro J,
Davis Z, Oscier D, Henriksson M, Sangfelt O, Grandér D and Corcoran
MM: DLEU2, frequently deleted in malignancy, functions as a
critical host gene of the cell cycle inhibitory microRNAs miR-15a
and miR-16-1. Exp Cell Res. 315:2941–2952. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kasinski AL and Slack FJ: Epigenetics and
genetics. MicroRNAs en route to the clinic: Progress in validating
and targeting microRNAs for cancer therapy. Nat Rev Cancer.
11:849–864. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Duan S, Dong X, Hai J, Jiang J, Wang W,
Yang J, Zhang W and Chen C: MicroRNA-135a-3p is downregulated and
serves as a tumour suppressor in ovarian cancer by targeting CCR2.
Biomed Pharmacother. 107:712–720. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Fukagawa S, Miyata K, Yotsumoto F,
Kiyoshima C, Nam SO, Anan H, Katsuda T, Miyahara D, Murata M, Yagi
H, et al: MicroRNA-135a-3p as a promising biomarker and nucleic
acid therapeutic agent for ovarian cancer. Cancer Sci. 108:886–896.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang SH, Zhang WJ, Wu XC, Weng MZ, Zhang
MD, Cai Q, Zhou D, Wang JD and Quan ZW: The lncRNA MALAT1 functions
as a competing endogenous RNA to regulate MCL-1 expression by
sponging miR-363-3p in gallbladder cancer. J Cell Mol Med.
20:2299–2308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Dong J, Geng J and Tan W: MiR-363-3p
suppresses tumor growth and metastasis of colorectal cancer via
targeting SphK2. Biomed Pharmacother. 105:922–931. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wang Y, Chen T, Huang H, Jiang Y, Yang L,
Lin Z, He H, Liu T, Wu B, Chen J, et al: miR-363-3p inhibits tumor
growth by targeting PCNA in lung adenocarcinoma. Oncotarget.
8:20133–20144. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Liu J, Li Q, Li R, Ren P and Dong S:
MicroRNA-363-3p inhibits papillary thyroid carcinoma progression by
targeting PIK3CA. Am J Cancer Res. 7:148–158. 2017.PubMed/NCBI
|
|
61
|
Li Y, Wang Y, Fan H, Zhang Z and Li N:
miR-125b-5p inhibits breast cancer cell proliferation, migration
and invasion by targeting KIAA1522. Biochem Biophys Res Commun.
504:277–282. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zhu Y, Zhang S, Li Z, Wang H, Li Z, Hu Y,
Chen H, Zhang X, Cui L, Zhang J, et al: miR-125b-5p and miR-99a-5p
downregulate human γδ T-cell activation and cytotoxicity. Cell Mol
Immunol. 16:112–125. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lee SB and Haber DA: Wilms tumor and the
WT1 gene. Exp Cell Res. 264:74–99. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kim JH, Hwang J, Jung JH, Lee HJ, Lee DY
and Kim SH: Molecular networks of FOXP family: Dual biologic
functions, interplay with other molecules and clinical implications
in cancer progression. Mol Cancer. 18:1802019. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Verhoeven Y, Tilborghs S, Jacobs J, De
Waele J, Quatannens D, Deben C, Prenen H, Pauwels P, Trinh XB,
Wouters A, et al: The potential and controversy of targeting STAT
family members in cancer. Semin Cancer Biol. 60:41–56. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Chen YL, Yuan RH, Yang WC, Hsu HC and Jeng
YM: The stem cell E3-ligase Lin-41 promotes liver cancer
progression through inhibition of microRNA-mediated gene silencing.
J Pathol. 229:486–496. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
De Cecco L, Negri T, Brich S, Mauro V,
Bozzi F, Dagrada G, Disciglio V, Sanfilippo R, Gronchi A, D'Incalci
M, et al: Identification of a gene expression driven progression
pathway in myxoid liposarcoma. Oncotarget. 5:5965–5977. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Yin J, Kim TH, Park N, Shin D, Choi HI,
Cho S, Park JB and Kim JH: TRIM71 suppresses tumorigenesis via
modulation of Lin28B-let-7-HMGA2 signaling. Oncotarget.
7:79854–79868. 2016. View Article : Google Scholar : PubMed/NCBI
|
